Memphis、TNにおける乳がんの臨床試験
Memphisとその周辺地域（約30マイル以内）の拠点で、乳がんに関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
被験者募集中第1/2相
- The West Cancer Center, Memphis
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
被験者募集中第1/2相
- Baptist Cancer Center - Memphis, Memphis
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
被験者募集中第3相
- Baptist Memorial Healthcare, Memphis
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
被験者募集中第2相
- West Cancer Center, Germantown · 14マイル先
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
被験者募集中
- West Cancer Center, Germantown · 14マイル先
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
被験者募集中第3相
- Clinical Trial Site, Bartlett · 11マイル先
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
被験者募集中第3相
- The West Clinic, P.C. dba West Cancer Center, Germantown · 14マイル先
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Baptist Cancer Center, Memphis
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
被験者募集中第1/2相
- The West Clinic, Germantown · 14マイル先
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
被験者募集中
- The West Clinic, PC dba West Cancer Center, Germantown · 14マイル先
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
被験者募集中第3相
- West Cancer Center, Germantown · 14マイル先
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12マイル先
- The West Clinic - Wolf River, Germantown · 14マイル先
- 他1件
E-Mindfulness Approaches for Living After Breast Cancer
被験者募集中第3相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12マイル先
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14マイル先
Familial Investigations of Childhood Cancer Predisposition
被験者募集中観察研究
- St. Jude Children's Research Hospital, Memphis
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
被験者募集中第3相
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14マイル先
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital for Women, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11マイル先
- 他1件
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
被験者募集中観察研究健康なボランティア歓迎
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Memphis
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
被験者募集中第3相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #11, Germantown · 14マイル先
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
被験者募集中観察研究
- West Cancer Center, Germantown · 14マイル先
他の都市における乳がんの試験
- New York City, NY136件の研究
- Houston, TX126件の研究
- Boston, MA112件の研究
- Nashville, TN81件の研究
- Los Angeles, CA73件の研究
- Edison, NJ68件の研究
- St. Louis, MO64件の研究
- Queens, NY64件の研究
- Durham, NC64件の研究
- Chicago, IL59件の研究
- Philadelphia, PA56件の研究
- Dallas, TX55件の研究
Memphisにおける他の研究
- がん（全種類）31件の研究
- 非小細胞肺癌23件の研究
- 肺がん18件の研究
- 鎌状赤血球症18件の研究
- 急性リンパ性白血病16件の研究
- 急性骨髄性白血病15件の研究
- 心不全13件の研究
- 軟部組織肉腫11件の研究
- 悪性黒色腫11件の研究
- 前立腺がん11件の研究
- 大腸癌11件の研究
- 骨肉腫10件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。